AzTrials
AzTrials

Neonatal HyperbilirubinemiaNCT07610811

Foot Reflexology and Massage in Neonates Receiving Phototherapy

A study testing Foot Reflexology, Body Massage and Phototherapy Device in people with Neonatal Hyperbilirubinemia, run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Neonatal hyperbilirubinemia is a common condition in newborns and is frequently treated with phototherapy. In addition to standard treatment, non-pharmacological interventions such as massage and foot reflexology may help reduce bilirubin levels and improve physiological stability and stress in newborns. Read more about this study

Who is it for?
Ages 2 to 10 days
Conditions the study is for
Neonatal Hyperbilirubinemia
What is being tested?
Foot Reflexology, Body Massage and Phototherapy Device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
105 participants
Where
1 siteTurkey (Türkiye)
Study dates
9 May 2026to 8 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 10 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Neonates whose parents/legal guardians have signed the informed consent form and agreed to participate in the study
  • Neonates born between 34 and 41 weeks of gestation
  • Birth weight of 2500 g or above
  • Not mechanically ventilated
  • No nasogastric tube
  • Stable vital signs
Show all 11Show fewer
  • No elevated acute phase reactants during phototherapy treatment
  • Indirect bilirubin level between 12 and 28 mg/dL at admission to the neonatal intensive care unit
  • Not receiving antibiotic treatment during the study
  • Aged between 2 and 10 days
  • No health problems other than indirect hyperbilirubinemia.

Who cannot join

  • Presence of any neurological anomaly
  • Presence of any congenital anomaly
  • Jaundice due to ABO incompatibility
  • Jaundice due to Rh incompatibility
  • Presence of dermal anomalies
  • Diagnosis of hyperbilirubinemia within the first 24 hours after birth
  • Diagnosis of direct hyperbilirubinemia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

yagmur karadas, PhD contact

+905072209435

yagmurerisen@gmail.com

ayten taspinar, Professor contact

+905362581624

ayten.taspinar@adu.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Kuşadası State Hospital

    Kusadasi, Aydın, 09400

    yağmur karadas, +90 5072209435, yagmurerisen@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Foot Reflexology and Massage on Total Serum Bilirubin, Physiological Parameters, and Stress in Neonates Receiving Phototherapy: A Randomized Controlled Trial

Neonatal hyperbilirubinemia is a common condition in newborns and is frequently treated with phototherapy. In addition to standard treatment, non-pharmacological interventions such as massage and foot reflexology may help reduce bilirubin levels and improve physiological stability and stress in newborns.

This randomized controlled trial aims to evaluate the effects of foot reflexology and body massage on total serum bilirubin levels, physiological parameters (heart rate, respiratory rate, oxygen saturation, and body temperature), and stress levels in neonates receiving phototherapy.

Read more

A total of 105 newborns will be randomly assigned to three groups: foot reflexology, body massage, and control group. Interventions will be applied before phototherapy sessions, and outcomes will be measured before and after the intervention.

The findings of this study are expected to provide evidence for the use of non-invasive complementary methods in reducing bilirubin levels and improving clinical outcomes in newborns.

Read the detailed description

Neonatal hyperbilirubinemia is one of the most common conditions requiring hospitalization in the early neonatal period. Although phototherapy is the standard treatment, it may be associated with potential short- and long-term adverse effects, including dehydration, thermoregulation disturbances, and increased stress responses. Therefore, there is growing interest in complementary, non-invasive interventions that may enhance treatment effectiveness and improve neonatal outcomes.

Massage therapy and foot reflexology are commonly used complementary interventions in neonatal care. These interventions are thought to stimulate the gastrointestinal system, increase bowel movements, and facilitate bilirubin excretion. In addition, they may contribute to improved physiological stability and reduced stress levels through tactile stimulation.

This study is designed as a randomized controlled trial to evaluate the effects of foot reflexology and body massage on total serum bilirubin levels, physiological parameters, and stress levels in neonates receiving phototherapy. Physiological parameters include heart rate, respiratory rate, oxygen saturation, and body temperature.

The study will be conducted in a neonatal intensive care unit and will include 105 neonates diagnosed with indirect hyperbilirubinemia. Participants will be randomly assigned to one of three groups: foot reflexology group, body massage group, and control group. Interventions will be administered prior to phototherapy sessions.

Data will be collected using standardized tools, including a Neonatal Information Form, Neonatal Follow-up Form, and a validated Neonatal Stress Scale. Outcome measures will be assessed before and after the interventions.

The findings of this study are expected to provide evidence on the effectiveness of complementary non-pharmacological interventions in reducing bilirubin levels, improving physiological stability, and decreasing stress in neonates. These results may contribute to the integration of evidence-based complementary practices into neonatal care.

Being tested
Foot Reflexology, Body Massage, Phototherapy Device
Keywords
Foot Reflexology, Neonatal Massage, Phototherapy, Neonate, Hyperbilirubinemia, Bilirubin, Non-pharmacological Intervention, Complementary Therapy, Neonatal Stress, Physiological Parameters
Medical subject headings
Hyperbilirubinemia, Neonatal, Hyperbilirubinemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Foot ReflexologyBehavioural

    Foot reflexology will be applied using gentle pressure techniques on specific reflex points of the feet prior to phototherapy sessions.

  • Body MassageBehavioural

    Body massage will be applied using gentle and systematic touch techniques prior to phototherapy sessions.

  • Phototherapy DeviceDevice

    Phototherapy will be provided using a standard phototherapy device according to the neonatal intensive care unit's routine clinical protocol for the management of neonatal indirect hyperbilirubinemia.

Study groups in NCT07610811
Study groupRoleWhat they receive
Foot Reflexology GroupExperimentalNeonates in this group will receive foot reflexology in addition to standard phototherapy care prior to phototherapy sessions.
Receives: Behavioral: Foot Reflexology
Body Massage GroupExperimentalNeonates in this group will receive body massage in addition to standard phototherapy care prior to phototherapy sessions.
Receives: Behavioral: Body Massage
Control GroupActive comparatorNeonates in this group will receive standard phototherapy care only without any additional intervention.
Receives: Device: Phototherapy Device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total Serum Bilirubin Level

    Total serum bilirubin level will be measured to evaluate the effect of foot reflexology and body massage on bilirubin reduction in neonates receiving phototherapy.

    Measured: Immediately before and immediately after each phototherapy session.

Secondary outcomes (5)
  1. Heart rate

    Heart rate will be assessed immediately before and immediately after each phototherapy session. The outcome will be reported as beats per minute.

    Measured: Immediately before and immediately after each phototherapy session.

  2. Respiratory Rate

    Respiratory rate will be assessed immediately before and immediately after each phototherapy session. The outcome will be reported as breaths per minute.

    Measured: Immediately before and immediately after each phototherapy session.

  3. Oxygen Saturation

    Oxygen saturation will be assessed immediately before and immediately after each phototherapy session. The outcome will be reported as percentage oxygen saturation.

    Measured: Immediately before and immediately after each phototherapy session.

  4. Body Temperature

    Body temperature will be assessed immediately before and immediately after each phototherapy session. The outcome will be reported in degrees Celsius.

    Measured: Immediately before and immediately after each phototherapy session.

  5. Neonatal Stress Level

    Neonatal stress level will be evaluated using the Newborn Stress Scale developed by Ceylan and Bolışık. This observational scale includes eight domains: facial expression, body color, respiration, activity level, consolability, muscle tone, extremities, and posture. Each domain reflects observable behavioral or physiological stress responses in the newborn, such as changes in facial expression, skin color, breathing pattern, motor activity, ability to be consoled, muscle tension, limb movements, and body posture. Items are scored from 0 to 2, with higher scores indicating a higher level of neonatal stress. The outcome will be reported as the total scale score.

    Measured: Immediately before and immediately after each phototherapy/intervention session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2026
  2. Study start9 May 2026
  3. Primary completion8 Mar 2027 (estimated)
  4. Study completion8 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of three parallel groups: foot reflexology group, body massage group, or control group. Each participant will remain in the assigned group throughout the study. The intervention groups will receive foot reflexology or body massage in addition to standard phototherapy care, while the control group will receive standard phototherapy care only.
Masking
None (open label)
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07610811
Sponsor's protocol ID
2025/008
Status last verified
Sep 2026
First submitted
8 May 2026
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to ethical and privacy considerations involving neonatal participants. Aggregated study findings may be shared through scientific publications and presentations.

Questions about this trial

What is this clinical trial studying?

A study testing Foot Reflexology, Body Massage and Phototherapy Device in people with Neonatal Hyperbilirubinemia, run by Aydin Adnan Menderes University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact yagmur karadas, PhD (+905072209435, yagmurerisen@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total Serum Bilirubin Level (time frame: Immediately before and immediately after each phototherapy session.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in